Condition: Cardiovascular Risk Factors · Sponsor: Hypertension Excellence Centre Lucerne
The planned research project is a prospective population-based cohort study, similar to the well-known Framingham study in the United States. So far, there is no similar research project in Switzerland. It is planned to examine of three Swiss municipalities. Recruitment in a first Swiss municipality (Lostallo/Cama GR) started 2014 and ended in 2019. Overall, 496 participants were recruited in this municipality. The five-year follow-up in this municipality started in 2019. It is planned to start recruitment in a second Swiss municipality (Uznach SG) in 2020. The examinations embrace a broad spectrum of measurements (for details the investigators refer to the published study protocol).
This description comes directly from the study's public registry record.
Paul Erne, MD · paul.erne@erne-net.ch
Andreas W Schoenenberger, MD · Andreas.Schoenenberger@insel.ch
Always discuss trial participation with your own doctor first.
| Linth Hospital | Uznach, Canton of St. Gallen, Switzerland | Recruiting |
| Cama | Cama, Kanton Graubünden, Switzerland | Recruiting |
| Lostallo | Lostallo, Kanton Graubünden, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02282748